Tentando aprender a traduzir a partir dos exemplos de tradução humana.
A partir de tradutores profissionais, empresas, páginas da web e repositórios de traduções disponíveis gratuitamente
bij die studie werd kaletra vergeleken met een voor iedere patiënt afzonderlijk door de studieonderzoeker gekozen proteaseremmer.
the second study included 118 adults who had taken another protease inhibitor in the past, comparing kaletra with a protease inhibitor chosen by the study investigator on a patient-by-patient basis.
Última atualização: 2011-10-23
Frequência de uso: 1
Qualidade:
Aviso: esta concordância pode estar incorreta.
Exclua-a, se este for o caso.
bij de tweede studie waren 118 volwassenen betrokken die in het verleden een andere proteaseremmer hadden gebruikt, en werden kaletra-capsules vergeleken met een voor iedere patiënt afzonderlijk door de studieonderzoeker gekozen proteaseremmer.
the second study included 118 adults who had taken another protease inhibitor in the past and compared kaletra capsules with a protease inhibitor chosen by the study investigator on a patient-by-patient basis.
Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:
bovendien werden in klinische onderzoeken bijwerkingen waargenomen, waarvan de studieonderzoeker oordeelde dat die vaccin- of placebo-gerelateerd waren, in frequenties van minder dan 1%.
in addition, in clinical trials adverse reactions that were judged to be vaccine- or placebo-related by the study investigator were observed at frequencies lower than 1%:
Última atualização: 2012-04-11
Frequência de uso: 2
Qualidade:
bij de gevallen die volgens de studieonderzoeker vaccingerelateerd waren, was de incidentie van otitis media (0,3%) en bronchospasme (< 0,1%) echter dezelfde bij de gevaccineerden met rotateq als deze bij de gevaccineerden met placebo.
otitis media and bronchospasm were reported in significantly more vaccine than placebo recipients overall; however, among cases that were considered to be vaccine-related in the opinion of the study investigator, the incidence of otitis media (0.3%) and bronchospasm (< 0.1%) was the same for vaccine and placebo recipients.
Última atualização: 2012-04-11
Frequência de uso: 2
Qualidade:
Aviso: contém formatação HTML invisível